ARCHIVES

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985

In Brief: The Children’s Oncology Group Is Name for Pediatric Trials Groups In Merger

June 25, 1999

House Committee Begins Investigation Of NCI’s National Lung Screening Trial.

October 26, 2007

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997

Sunitinib May Be Associated With Cardiac Toxicity

January 25, 2008